Abstract
Purpose
The lack of effective screening methods and systemic understanding of interaction mechanisms complicates the stabilizer selection process for nanocrystallization. This study focuses on the efficiency of stabilizers with various molecular compositions and structures to stabilize drug nanocrystals.
Methods
Five structurally different polymers were chosen as stabilizers for indomethacin nanocrystals. The affinity of polymers onto drug surfaces was measured using surface plasmon resonance (SPR) and contact angle techniques. Nanosuspensions were prepared using the wet-ball milling technique and their physico-chemical properties were thoroughly characterized.
Results
SPR and contact angle measurements correlated very well with each other and showed that the binding efficiency decreased in the order L64 > 17R4 > F68 ≈ T908 ≈ T1107, which is attributed to the reduced PPO/PEO ratio and different polymer structures. The electrostatic interactions between the protonated amine of poloxamines and ionized indomethacin enhanced neither the affinity nor the properties of nanosuspensions, such as particle size and physical stability.
Conclusions
A good stabilizer should have high binding efficiency, full coverage, and optimal hydrophobic/hydrophilic balance. A high affinity combined with short PEO chains (L64, 17R4) caused poor physical stability of nanosuspensions, whereas moderate binding efficiencies (F68, T908, T1107) with longer PEO chains produced physically stable nanosuspensions.
Similar content being viewed by others
References
Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 2004;3:785–96.
Müller RH, Gohla S, Keck CM. State of the art of nanocrystals - special features, production, nanotoxicology aspects and intracellular delivery. Eur J Pharm Biopharm. 2011;78(1):1–9.
Moschwitzer JP. Drug nanocrystals in the commercial pharmaceutical development process. Int J Pharm. 2013;453(1):142–56.
Shegokar R, Müller RH. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. Int J Pharm. 2010;399(1–2):129–39.
Lindfors L, Forssen S, Westergren J, Olsson U. Nucleation and crystal growth in supersaturated solutions of a model drug. J Colloid Interf Sci. 2008;325(2):404–13.
Lee J, Choi JY, Park CH. Characteristics of polymers enabling nano-comminution of water-insoluble drugs. Int J Pharm. 2008;355(1–2):328–36.
Lai F, Sinico C, Ennas G, Marongiu F, Marongiu G, Fadda AM. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour. Int J Pharm. 2009;373(1–2):124–32.
Xiong R, Lu W, Li J, Wang P, Xu R, Chen T. Preparation and characterization of intravenously injectable nimodipine nanosuspension. Int J Pharm. 2008;350(1–2):338–43.
Douroumis D, Fahr A. Stable carbamazepine colloidal systems using the cosolvent technique. Eur J Pharm Sci. 2007;30(5):367–74.
Cerdeira AM, Mazzotti M, Gander B. Miconazole nanosuspensions: influence of formulation variables on particle size reduction and physical stability. Int J Pharm. 2010;396(1–2):210–8.
Dolenc A, Kristl J, Baumgartner S, Planinsek O. Advantages of celecoxib nanosuspension formulation and transformation into tablets. Int J Pharm. 2009;376:204–12.
Mauludin R, Müller RH, Keck CM. Development of an oral rutin nanocrystal formulation. Int J Pharm. 2009;370:202–9.
Mauludin R, Müller RH, Keck CM. Kinetic solubility and dissolution velocity of rutin nanocrystals. Eur J Pharm Sci. 2009;36:502–10.
Guo Y, Luo J, Tan S, Otieno BO, Zhang Z. The applications of vitamin E TPGS in drug delivery. Eur J Pharm Sci. 2013;49:175–86.
Peltonen L, Hirvonen J. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods. J Pharm Pharmacol. 2010;62:1569–79.
Van Eerdenbrugh B, Vermant J, Martens JA, Froyen L, Van Humbeeck J, Augustijns P, et al. A screening study of surface stabilization during the production of drug nanocrystals. J Pharm Sci. 2009;98(6):2091–103.
Sepassi S, Goodwin DJ, Drake AF, Holland S, Leonard G, Martini L, et al. Effect of polymer molecular weight on the production of drug nanoparticles. J Pharm Sci. 2007;96(10):2655–66.
Lee J, Lee SJ, Choi JY, Yoo JY, Ahn CH. Amphiphilic amino acid copolymers as stabilizers for the preparation of nanocrystal dispersion. Eur J Pharm Sci. 2005;24(5):441–9.
Lee MK, Kim S, Ahn CH, Lee J. Hydrophilic and hydrophobic amino acid copolymers for nano-comminution of poorly soluble drugs. Int J Pharm. 2010;384:173–80.
Moghimi SM, Hunter AC. Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. Trends Biotechnol. 2000;18(10):412–20.
Alvarez-Lorenzo C, Sosnik A, Concheiro A. PEO-PPO block copolymers for passive micellar targeting and overcoming multidrug resistance in cancer therapy. Curr Drug Targets. 2011;12(8):1112–30.
Alvarez-Lorenzo C, Rey-Rico A, Sosnik A, Taboada P, Concheiro A. Poloxamine-based nanomaterials for drug delivery. Front biosci (Elite ed). 2010;2:424–40.
Chiappetta DA, Sosnik A. Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugs. Eur J Pharm Biopharm. 2007;66(3):303–17.
Knoll W. http://www2.mpip-mainz.mpg.de/groups/knoll/software.
Liu P, De Wulf O, Laru J, Heikkilä T, Van Veen B, Kiesvaara J, et al. Dissolution studies of poorly soluble drug nanosuspensions in non-sink conditions. AAPS PharmSciTech. 2013;14:748–56.
Pardeike J, Müller RH. Nanosuspensions: a promising formulation for the new phospholipase A(2) inhibitor PX-18. Int J Pharm. 2010;391:322–9.
Pardeike J, Strohmeier DM, Schröedl N, Voura C, Gruber M, Khinast JC, et al. Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines. Int J Pharm. 2011;420(1):93–100.
Watanabe A. A trial production of a table of the optical crystallographic characteristics of crystalline drugs including crystal habits (study of crystalline drugs by means of a polarizing microscope. XIX Yakugaku zasshi. 2002;122(8):595–606.
Love JC, Estroff LA, Kriebel JK, Nuzzo RG, Whitesides GM. Self-assembled monolayers of thiolates on metals as a form of nanotechnology. Chem Rev. 2005;105(4):1103–69.
Gustafsson SS, Vrang L, Terelius Y, Danielson UH. Quantification of interactions between drug leads and serum proteins by use of “binding efficiency”. Anal Biochem. 2011;409(2):163–75.
Mende S, Stenger F, Peukert W, Schwedes J. Mechanical production and stabilization of submicron particles in stirred media mills. Powder Technol. 2003;132:64–73.
Sezgin Z, Yüksel N, Baykara T. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur J Pharm Biopharm. 2006;64(3):261–8.
Bilgili E, Afolabi A. A combined microhydrodynamics-polymer adsorption analysis for elucidation of the roles of stabilizers in wet stirred media milling. Int J Pharm. 2012;439:193–206.
Alvarez-Lorenzo C, Gonzalez-Lopez J, Fernandez-Tarrio M, Sandez-Macho I, Concheiro A. Tetronic micellization, gelation and drug solubilization: Influence of pH and ionic strength. Eur J Pharm Biopharm. 2007;66(2):244–52.
Liu P, Rong X, Laru J, Van Veen B, Kiesvaara J, Hirvonen J, et al. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. Int J Pharm. 2011;411:215–22.
Chaubal MV, Popescu C. Conversion of nanosuspensions into dry powders by spray drying: a case study. Pharm Res. 2008;25(10):2302–8.
Verma S, Kumar S, Gokhale R, Burgess DJ. Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening. Int J Pharm. 2011;406:145–52.
Sarkar B, Venugopal V, Tsianou M, Alexandridis P. Adsorption of pluronic block copolymers on silica nanoparticles. Colloid Surf A. 2013;422:155–64.
Bergaya F, Lagaly G. Developments in Clay Science. Oxford: Elsevier; 2012.
Goodwin DJ, Sepassi S, King SM, Holland SJ, Martini LG, Lawrence MJ. Characterization of polymer adsorption onto drug nanoparticles using depletion measurements and small-angle neutron scattering. Mol Pharm. 2013;10:4146–58.
Malmsten M, Linse P, Cosgrove T. Adsorption of PEO-PPO-PEO block copolymers at silica. Macromolecules. 1992;25:2474–81.
Lambert O, Jada A, Dumas P. Adsorption of triarm starblock copolymers based on polystyrene, poly(ethylene oxide) and poly(e-caprolactone) at the solid-solution interface. Colloid Surf A. 1998;136:263–72.
Jain TK, Erokwu B, Dimitrijevic S, Flask CA, Labhasetwar V. Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice. Biomaterials. 2009;30(35):6748–56.
Acknowledgments
The authors acknowledge The Finnish Funding Agency for Innovation (TEKES, Finland; NanoForm project 40187/11) China Scholarship Council and The Academy of Finland for financial support. M.Sc. May Mah from University of Otago and M.Sc. Dongfei Liu from University of Helsinki are acknowledged for valuable discussion and suggestions, and Dr. Petri Ihalainen for providing the AFM image of the indomethacin layer precipitated on the SPR sensor slide.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, P., Viitala, T., Kartal-Hodzic, A. et al. Interaction Studies Between Indomethacin Nanocrystals and PEO/PPO Copolymer Stabilizers. Pharm Res 32, 628–639 (2015). https://doi.org/10.1007/s11095-014-1491-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-014-1491-3